Aprea Therapeutics Inc share price logo

Aprea Therapeutics Inc Share Price

NASDAQ: APRE

Small Cap

$1.01

+0.10

(+11.27%)

as on

Aprea Therapeutics Inc Stock Performance

as on April 18, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $0.91
    $1.12
    downward going graph

    9.90%

    Downside

    10.89%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.55
    $2.22
    downward going graph

    45.74%

    Downside

    119.80%

    Upside

    downward going graph

Aprea Therapeutics Inc share price movements today

Previous Close
$0.91
Open
$0.91
Volume
1.8M
Day's Low - High
$0.91 - $1.12
52 Week Low - High
$0.55 - $2.22

Aprea Therapeutics Inc Historical Returns

1 Month Return
+ 16.04 %
3 Month Return
+ 1.99 %
1 Year Return
-39.5 %
3 Year Return
-77.59 %
5 Year Return
-99.02 %

Aprea Therapeutics Inc Stock Fundamentals & Key Indicators

Check Aprea Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$10.8M

EPS (TTM)

-0.805

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-13.2M

Revenue (TTM)

285.8K

Profit Margin

0.00%

Return On Equity TTM

-74.58%

Aprea Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Aprea Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Aprea Therapeutics Inc image
Aprea Therapeutics Inc
BUY$10.8M-99.02%NA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$42.7B130.51%136.818.45%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$110.8B98.57%28.4232.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$36.8BNA129.845.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$78.9B48.43%17.9831.41%

Stock Returns calculator for Aprea Therapeutics Inc Stock including INR - Dollar returns

The Aprea Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Aprea Therapeutics Inc investment value today

Current value as on today

₹73,151

Returns

-₹26,849

(-26.85%)

Returns from Aprea Therapeutics Inc Stock

-₹32,667 (-32.67%)

Dollar Impact

₹5,818 (+5.82%)

Analyst Recommendation on Aprea Therapeutics Inc Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Aprea Therapeutics Inc. Average target price of $4.4

Aprea Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Aprea Therapeutics Inc.

What analysts predicted

77.05%UPSIDE

Target Price

$4.4

Current Price

$1.01

Analyzed by

9 Analysts

Target

$4.40

Aprea Therapeutics Inc target price $4.4, a slight upside of 77.05% compared to current price of $1.01. According to 9 analysts rating.

Aprea Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Aprea Therapeutics Inc Stock has decreased by -49% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-49% versus previous 30 day period

Aprea Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
0
0
0
0
0
0
0
0
0
0
Gross Profit
-1
-2
-1
-1
-2
-2
-2
-1
0
4
Operating Income
-3
-3
-3
-3
-4
-3
-4
-3
-3
-2
EBITDA
-3
-3
-3
-3
-4
-3
-4
-3
-2
-2
Interest Expense
-
0
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-3
-3
-2
-3
-3
-2
-3
-3
-2
-2
Income Tax Expense
0
0
0
0
-
0
-
-
-
-
Net Income
-3
-3
-2
-3
-3
-2
-3
-3
-2
-2
Net Profit Margin
-1003.08%
-24463.62%
-738.39%
-617.92%
-1066.99%
-1406.49%
-2420.65%
-2742.23%
-160844.70%
-73587.95%

Aprea Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2013
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
0
1
0
Gross Profit
-
0
0
0
0
0
-16
0
-7
0
Operating Income
0
-15
-16
-29
-52
-37
-113
-15
-14
-13
EBITDA
-
-15
-15
-27
-53
-36
-37
-14
-14
-13
Interest Expense
-
0
0
0
0
0
0
-
-
-
Depreciation
-
0
0
0
0
0
0
0
0
0
Income Before Tax
0
-15
-15
-28
-53
-37
-112
-14
-12
-12
Income Tax Expense
-
0
0
-1
0
0
112
0
-
-
Net Income
0
-15
-15
-28
-53
-36
-112
-14
-12
-12
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-2449.59%
-862.43%
-4409.16%

Aprea Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-3
-2
-3
-3
-2
-3
-3
-2
-2
Operating Cash Flow
-3
-3
-3
-2
-3
-3
-3
-3
-3
Investing Cash Flow
0
0
0
0
0
-
-
-
-
Financing Cash Flow
0
14
0
0
0
0
0
0
4
Change in Cash
-3
10
-3
-2
-3
-3
-2
-2
0

Aprea Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-15
-15
-28
-53
-37
-112
-14
-12
-12
Operating Cash Flow
-14
-15
-26
-41
-37
-25
-12
-13
-12
Investing Cash Flow
0
0
0
0
-
-
0
0
-
Financing Cash Flow
23
56
92
0
1
0
5
14
4
Change in Cash
10
41
64
-41
-35
-24
-7
1
-8

Global Institutional Holdings in Aprea Therapeutics Inc

Funds
Holdings
Vanguard Group Inc
0.51%
Jane Street Group LLC
0.41%
Dimensional Fund Advisors, Inc.
0.25%
BNP Paribas Arbitrage, SA
0.24%
Advisor Group Holdings, Inc.
0%
See all

Insights on Aprea Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, APRE stock has moved up by 16.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Beone Medicines Ltd has given 38.8% return, outperforming this stock by 78.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 21.1% return, outperforming this stock by 98.7%

About Aprea Therapeutics Inc

Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidates are APR-1051, an orally bioavailable small-molecule inhibitor of WEE1 kinase that is in Phase 1 clinical trial for the treatment of patients with advanced solid tumors with biomarkers and ATRN-119, an ATR inhibitor, which is in Phase 1/2a clinical trial for solid tumor indications. The company is headquartered in Doylestown, Pennsylvania.
OrganisationAprea Therapeutics Inc
Headquarters3805 Old Easton Road, Doylestown, PA, United States, 18902
IndustryBiotechnology
CEODr. Oren Gilad Ph.D.
E-voting on sharesClick here to vote

Key Management of Aprea Therapeutics Inc

Name

Title

Dr. Oren Gilad Ph.D.

Co-Founder, CEO, President & Director

Mr. John P. Hamill CPA

Senior VP, CFO, Principal Accounting Officer & Secretary

Dr. Lars B. Abrahmsen Ph.D.

Senior VP & Chief Scientific Officer

Mr. Brian Wiley

Senior Vice President of Corporate Development & Strategy

Dr. Michel Afargan Ph.D.

Head of Pharmacology Development

Mr. Ze'ev Weiss B.Sc., C.P.A.

Chief Business Advisor

Dr. Eugene P. Kennedy F.A.C.S., M.D.

Chief Medical Advisor

Ms. Andrea Epstein

Controller

FAQs

What is Aprea Therapeutics Inc share price today?

Aprea Therapeutics Inc share price today is $1.01 as on at the close of the market. Aprea Therapeutics Inc share today touched a day high of $1.12 and a low of $0.91.

What is the 52 week high and 52 week low for Aprea Therapeutics Inc share?

Aprea Therapeutics Inc share touched a 52 week high of $2.22 on and a 52 week low of $0.55 on . Aprea Therapeutics Inc stock price today i.e. is closed at $1.01,which is 54.50% down from its 52 week high and 84.31% up from its 52 week low.

What is Aprea Therapeutics Inc's market capitalisation today?

Aprea Therapeutics Inc market capitalisation is $0.00T as on .

How to invest in Aprea Therapeutics Inc Stock (APRE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Aprea Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Aprea Therapeutics Inc Shares that will get you 1.4851 shares as per Aprea Therapeutics Inc share price of $1.01 per share as on April 18, 2026 at 1:29 am IST.

What is the minimum amount required to buy Aprea Therapeutics Inc Stock (APRE) from India?

Indian investors can start investing in Aprea Therapeutics Inc (APRE) shares with as little as ₹92.768 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹927.68 in Aprea Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Aprea Therapeutics Inc share’s latest price of $1.01 as on April 18, 2026 at 1:29 am IST, you will get 9.9010 shares of Aprea Therapeutics Inc. Learn more about fractional shares .

What are the returns that Aprea Therapeutics Inc has given to Indian investors in the last 5 years?

Aprea Therapeutics Inc stock has given -99.02% share price returns and 24.45% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?